All News
Filter News
Found 808,645 articles
-
Boston Scientific Corporation Release: Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents As Safe As Bare-Metal Stents And Far More Effective In Reducing Repeat Procedures
12/7/2006
-
On A Roll
12/7/2006
-
Eli Lilly and Company Submits New Drug Application For EVISTA For Reduction Of Invasive Breast Cancer Risk In Postmenopausal Women
12/7/2006
-
HRA Pharma Commences US Phase III Trial Of Second-Generation Emergency Contraceptive
12/7/2006
-
Titan Pharmaceuticals Reports Positive Results In Iloperidone Phase III Clinical Trial
12/7/2006
-
Cardium Therapeutics, Inc.'s Generx Advances To Phase 3 Following Meeting With FDA
12/7/2006
-
BioMS Medical's Pivotal Multiple Sclerosis Trial Receives Sixth Positive Review From Data Safety Monitoring Board
12/7/2006
-
Othera Pharmaceuticals And The National Eye Institute Commence Dry AMD Study
12/7/2006
-
BioTime Announces A Phase II Clinical Trial Of Hextend(R) In Japan
12/7/2006
-
MethylGene Initiates Phase II Clinical Trial With Its Proprietary HDAC Inhibitor, MGCD0103, In High-Risk Myelodysplastic Syndromes 'MDS' And Acute Myelogenous Leukemia 'AML'
12/7/2006
-
Omrix Biopharmaceuticals, Inc. Commences Phase 1 Clinical Trial For Fibrin Patch
12/7/2006
-
Clinical Data On Pharmion Corporation's Epigenetic Therapies In Higher-Risk MDS, AML And Other Hematological Malignancies To Be Presented At The American Society of Hematology 2006 Annual Meeting
12/7/2006
-
EPIX Pharmaceuticals, Inc. Presents Findings From PRX-08066 Clinical Trials At National Institutes of Health (NIH) Pulmonary Hypertension Meeting
12/7/2006
-
AVI BioPharma, Inc. Announces Clinical Development Initiative For Muscular Dystrophy
12/7/2006
-
VistaGen Therapeutics, Inc. Announces Positive AV-101 Preclinical Data Suggesting Potential For Parkinson's Disease
12/7/2006
-
Memory Pharmaceuticals Presents Data For MEM 3454 And MEM 1003 At The American College Of Neuropsychopharmacology Annual Meeting
12/7/2006
-
Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical And Pre-Clinical Activity Of KRX-0401 (Perifosine) At The Upcoming American Society of Hematology
12/7/2006
-
AEterna Zentaris Announces Poster Presentations Highlighting Clinical And Preclinical Activity Of Perifosine (KRX-0401) At The American Society of Hematology 48th Annual Meeting
12/7/2006
-
Novartis Pharmaceuticals Corporation Release: Gleevec(R) Demonstrates Highest Five-Year Overall Survival Rate In History Of Treatment For Patients With Chronic Myeloid Leukemia
12/7/2006
-
FDA Panel To Hear New Data From Kaiser Permanente Experts On Drug-Eluting Heart Stents
12/7/2006